| Breaking “bad” links: impact of companies act 2013 on the Indian Corporate Network M Aggarwal, AS Chakrabarti, P Dev Social networks 62, 12-23, 2020 | 11 | 2020 |
| Research and market structure: Evidence from an antibiotic-resistant pathogenic outbreak M Aggarwal, AS Chakrabarti, C Chatterjee, MJ Higgins Research Policy 52 (1), 104633, 2023 | 3 | 2023 |
| Movies, stigma and choice: Evidence from the pharmaceutical industry M Aggarwal, AS Chakrabarti, C Chatterjee Health Economics 32 (5), 1019-1039, 2023 | | 2023 |
| Ecosystem Uncertainty and Technology Reemergence: H1N1 Pandemic and Ayurveda Reemergence M Aggarwal Academy of Management Proceedings 2022 (1), 14473, 2022 | | 2022 |
| Organizing for Value Creation and Managing Risk: Study of Indian Pharmaceutical Ecosystem M Aggarwal Academy of Management Proceedings 2021 (1), 12967, 2021 | | 2021 |
| The Cost and Benefits of Platforms: Study of Amazon Inc. M Aggarwal Academy of Management Proceedings 2019 (1), 13302, 2019 | | 2019 |
| Markets Home Country Ecosystem Partners and Value Creation A Study of Indian Pharmaceutical Industry M Aggarwal Ahmedabad, 0 | | |
Chirantan ChatterjeeProfessor of Economics of Innovation & Global Health, SPRU, Business School, University of SussexVerified email at sussex.ac.uk
